AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.56% and +4.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

U.S. President Donald Trump recently had a medical checkup after noticing "mild swelling" in his lower legs and was found to ...